Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen1, Di Wu1, Huilong Chen1

  • 1Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

BMJ (Clinical Research Ed.)
|March 29, 2020
PubMed

Insights

Older age, male sex, and cardiovascular comorbidities increase the risk of death in patients with coronavirus disease 2019 (COVID-19). Common complications include acute respiratory distress syndrome, sepsis, and cardiac injury.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Cardiology

Background:

  • Coronavirus disease 2019 (COVID-19) is a severe respiratory illness caused by SARS-CoV-2.
  • Understanding risk factors and clinical characteristics of fatal COVID-19 cases is crucial for improving patient outcomes.
  • Previous studies have highlighted various clinical features, but a detailed analysis of deceased patients is essential.

Purpose of the Study:

  • To delineate the clinical characteristics and laboratory findings of patients with COVID-19 who died.
  • To identify risk factors and common complications associated with mortality in COVID-19 patients.

Main Methods:

  • Retrospective case series analysis of 799 patients diagnosed with COVID-19.
  • Data collection from electronic medical records at Tongji Hospital in Wuhan, China, until February 28, 2020.
  • Comparison of clinical and laboratory data between deceased patients (n=113) and recovered patients (n=161).

Main Results:

  • Deceased patients were significantly older (median 68 years vs. 51 years) and predominantly male (73% vs. 55%).
  • Higher prevalence of chronic hypertension (48% vs. 24%) and cardiovascular comorbidities (14% vs. 4%) in deceased patients.
  • Common symptoms in deceased patients included dyspnea (62%), chest tightness (49%), and altered consciousness (22%).
  • Leukocytosis (50% vs. 4%) and lymphopenia (91% vs. 47%) were more frequent in deceased patients.
  • Elevated levels of liver enzymes, cardiac markers, kidney function tests, and D-dimer were observed in non-survivors.
  • Frequent complications in deceased patients were ARDS (100%), sepsis (100%), acute cardiac injury (77%), and heart failure (49%).

Conclusions:

  • COVID-19 can lead to multi-organ dysfunction, particularly in high-risk individuals.
  • Acute respiratory distress syndrome, respiratory failure, sepsis, acute cardiac injury, and heart failure are critical complications.
  • Cardiovascular comorbidities are associated with increased risk of cardiac complications and mortality in COVID-19.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
923
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
715
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
245
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
374
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
666